Cargando…
Discovery of a Metastatic Immune Escape Mechanism Initiated by the Loss of Expression of the Tumour Biomarker Interleukin-33
A new paradigm for understanding immune-surveillance and immune escape in cancer is described here. Metastatic carcinomas express reduced levels of IL-33 and diminished levels of antigen processing machinery (APM), compared to syngeneic primary tumours. Complementation of IL-33 expression in metasta...
Autores principales: | Saranchova, Iryna, Han, Jeffrey, Huang, Hui, Fenninger, Franz, Choi, Kyung Bok, Munro, Lonna, Pfeifer, Cheryl, Welch, Ian, Wyatt, Alexander W., Fazli, Ladan, Gleave, Martin E., Jefferies, Wilfred A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5020406/ https://www.ncbi.nlm.nih.gov/pubmed/27619158 http://dx.doi.org/10.1038/srep30555 |
Ejemplares similares
-
Type 2 Innate Lymphocytes Actuate Immunity Against Tumours and Limit Cancer Metastasis
por: Saranchova, Iryna, et al.
Publicado: (2018) -
Curcuphenol possesses an unusual histone deacetylase enhancing activity that counters immune escape in metastatic tumours
por: Ellis, Samantha L. S., et al.
Publicado: (2023) -
Serum free culture for the expansion and study of type 2 innate lymphoid cells
por: de Lucía Finkel, Pablo, et al.
Publicado: (2021) -
Mutation of an L-Type Calcium Channel Gene Leads to T Lymphocyte Dysfunction
por: Fenninger, Franz, et al.
Publicado: (2019) -
A novel cell-based screen identifies chemical entities that reverse the immune-escape phenotype of metastatic tumours
por: Nohara, Lilian L., et al.
Publicado: (2023)